Search consultations



Changes to funding of Ciproflaxin for chronic suppurative otitis media (CSOM)

NZNO seeks members’ feedback on PHARMAC’s proposal to widen access to ciproflaxin eyedrops for the treatment of chronic suppurative otitis media (CSOM).

Please note this proposal was amended on 14 August following concerns around its use in otitis externa.

Access the amended proposal here:

Feedback due: Please send feedback to by 25 August 2017.